Xu Ruoyan: Difference between revisions
From Bioblast
No edit summary |
Beno Marija (talk | contribs) Β |
||
(3 intermediate revisions by one other user not shown) | |||
Line 12: | Line 12: | ||
|city=London | |city=London | ||
|country=United Kingdom | |country=United Kingdom | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
== Participated at == | |||
::::* [[IOC96|IOC96 Schroecken AT]] |
Latest revision as of 15:46, 13 February 2018
Name | Xu Ruoyan, |
---|---|
Institution | Centre for Molecular Oncology
Barts Cancer Institute - a Cancer Research UK Centre of Excellence Queen Mary, University of London John Vane Science Centre |
Address | Charterhouse Square, EC1M 6BQ |
City | London |
State/Province | |
Country | United Kingdom |
[email protected] | |
Weblink | |
O2k-Network Lab | UK London Bianchi K |
Labels:
Publications
Published | Reference | |
---|---|---|
Li 2014 Mol Cell Biol | 2014 | Li S, Yao Y, Xu R, Pesenti S, Cottet-Rousselle C, Rieusset J, Tokarska-Schlattner M, Liao K, Schlattner U, Rousseau D (2014) ATAD3 is a limiting factor in mitochondrial biogenesis and adipogenesis of white adipocyte-like 3T3-L1 cells. Mol Cell Biol 37. |
Abstracts
Published | Reference | |
---|---|---|
Xu 2014 Abstract IOC96 | 2014 | Xu R (2014) Exploring the role of IKKΞ΅ in cancer metabolism. Mitochondr Physiol Network 19.11. |